🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Goldman Sachs Announces $750M Deal To Acquire United Capital

Published 05/17/2019, 07:45 AM
Updated 07/09/2023, 06:31 AM
C
-
GS
-
MS
-
SF
-

The Goldman Sachs Group (NYSE:GS) has announced a $750 million all-cash deal to acquire United Capital Financial Partners — a boutique wealth-management firm — to expand client reach and get access to the latter’s enhanced digital platform.

The deal is expected to close in third-quarter 2019. Per the terms, Joe Duran, founder and CEO of United Capital, and his team of employees will join Goldman Sachs.

With about $25 billion in assets under management, United Capital offers financial life and investment management services through its subsidiary, United Capital Financial Advisers. It also offers wealth management services through its digital platform — FinLife CX.

Two-Fold Acquisition Benefits

Goldman Sachs offers wealth management services through two units — Private Wealth Management and Ayco. At present, the Wall Street giant offers services to the ultra-high net worth market through Private Wealth Management unit. However, with this acquisition, not only will Goldman have access to the mass affluent clients base of United Capital but will also be able to attract more such clients.

Also, the company expects this acquisition to bolster Ayco that provides financial planning and advice to corporate executives. Ayco will be able to cater needs of a broad range of clients with help of an “advisor-led, tech-enabled platform with considerable scale and geographic footprint.”

Wealth Management Expansion Drive in Wall Street

The Fed’s dovish monetary policy, concerns related to unsolved U.S.-China trade deal negotiations and expectation of global economic slowdown have taken a toll on trading revenues. Thus major Wall Street banks are diverting attention to more stable sources of revenues, such as wealth management.

Recently, Morgan Stanley (NYSE:MS) acquired Solium Capital Inc. that helped it gain access to Solium’s corporate clients and their employees. This acquisition will aid in bringing Solium’s major stock plan administration platform together with the leading Wealth Management business, thereby, positioning Morgan Stanley as an industry leader in Workplace Wealth Solutions.

Also, Citigroup (NYSE:C) is expanding reach in Asia Pacific by targeting clients with investible assets between $100,000 and $10 million in 17 markets. The company seeks to achieve this by combining world class advisory services from its trained managers with enhanced wealth management digital platform, including remote advisory and wealth management tools.

Our Take

Goldman’s efforts to diversify into more reliable and stable source of revenues bode well. Its consumer lending business seems impressive as well. Also, it is tapping into the large addressable market of consumer deposits with its digital consumer lending platform — Marcus. However, Goldman continues to encounter probes and queries from several federal agencies, which remains a concern.

Shares of the company have recorded slight gain in the past three months against 4.5% decline of its industry.

Goldman currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

A better-ranked stock in the same space is Stifel Financial Corporation (NYSE:SF) , currently sporting a Zacks Rank #1. Over the past 30 days, the company has witnessed 2.9% upward earnings estimate revision for the current year. Its shares have gained 6.4% in the past three months.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Citigroup Inc. (C): Free Stock Analysis Report

Stifel Financial Corporation (SF): Free Stock Analysis Report

The Goldman Sachs Group, Inc. (GS): Free Stock Analysis Report

Morgan Stanley (MS): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.